CP
EW icon

Canopy Partners’s Edwards Lifesciences EW Stock Holding History

Canopy Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$700K Buy
7,739
+528
+7% +$44.2K 0.21% 92
2026
Q1 		$577K Buy
7,211
+196
+3% +$16.2K 0.2% 96
2025
Q4 		$598K Sell
7,015
-328
-4% -$26.9K 0.19% 100
2025
Q3 		$571K Sell
7,343
-84
-1% -$6.56K 0.19% 95
2025
Q2 		$581K Sell
7,427
-49
-0.7% -$3.65K 0.21% 93
2025
Q1 		$542K Hold
7,476
– – 0.21% 95
2024
Q4 		$553K Sell
7,476
-176
-2% -$12.3K 0.21% 96
2024
Q3 		$505K Sell
7,652
-1,506
-16% -$109K 0.22% 95
2024
Q2 		$846K Sell
9,158
-18
-0.2% -$1.59K 0.39% 57
2024
Q1 		$877K Buy
9,176
+158
+2% +$13.3K 0.43% 49
2023
Q4 		$688K Buy
+9,018
New +$627K 0.42% 53

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Canopy Partners's EW Position: Q2 2026 in Review

Canopy Partners increased its Edwards Lifesciences (EW) stake by 7.3% in Q2 2026, buying an estimated $44.2K and bringing the position to 7,739 shares worth $700K. The position accounts for 0.21% of the portfolio, ranked #92.

Canopy Partners first reported a position in EW in Q4 2023 and has held it in 11 quarters since. The position peaked at $877K in Q1 2024. 353 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Canopy Partners held 7,739 shares of Edwards Lifesciences worth $700K as of Q2 2026.
  • Canopy Partners bought 528 Edwards Lifesciences shares in Q2 2026, an estimated $44.2K.
  • Edwards Lifesciences made up 0.21% of Canopy Partners's portfolio in Q2 2026, its #92 holding.
  • Canopy Partners first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • Canopy Partners's Edwards Lifesciences position peaked at $877K in Q1 2024.
  • 353 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Canopy Partners's 13F filing for Q2 2026, filed 22 Jul 2026.